The structural basis of MHC control of collagen-induced arthritis; Binding of the immunodominant type II collagen 256-270 glycopeptide to H-2A(q) and H-2A(p) molecules

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 755-766

  Kjellén, Peter ^a   Brunsberg, Ulrica ^a   Broddefalk, Johan ^b   Hansen, Bjarke ^c   Vestberg, Mikael ^a   Ivarsson, Ianeric ^a   Engström, Åke ^d   Svejgaard, Arne ^c   Kihlberg, Jan ^b   Fugger, Lars ^e   Holmdahl, Rikard ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c University of Copenhagen   (Denmark)

^d UPPSALA UNIVERSITY   (Sweden)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autoimmunity; Glycosylated peptide; Peptide binding; T cell

Indexed keywords

ALANINE; ASPARTIC ACID; COLLAGEN TYPE 2; GLYCOPEPTIDE; H2 ANTIGEN; ISOLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHENYLALANINE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 15444342696     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2     Document Type: Article

References (36)

1. Gregersen, P. K., Silver, J. and Winchester, R. J., The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987. 30: 1205-1213.
2. Rönnelid, J., Lysholm, J., Engström-Laurent, A., Klareskog, L. and Heyman, B., Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994. 37: 1023-1029.
3. Pereira, R. S., Black, C. M., Duance, V. C., Jones, V. E., Jacoby, R. K. and Welsh, K. I., Disappearing collagen antibodies in rheumatoid arthritis. Lancet 1985. ii: 501-502.
4. Fugger, L., Rothbard, J. B. and Sonderstrup-McDevitt, G., Specificity of an HLA-DRB1*0401-restricted T cell responce to type II collagen. Eur. J. Immunol. 1996. 26: 928-933.
5. Brunsberg, U., Gustafsson, K., Jansson, L., Michaëlsson, E., Ährlund-Richter, L., Pettersson, S., Mattsson, R. and Holmdahl, R., Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur. J. Immunol. 1994. 24: 1698-1702.
6. Myers, L. K., Stuart, J. M., Seyer, J. M. and Kang, A. H., Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J. Exp. Med. 1989. 170: 1999-2010.
7. Andersson, M. and Holmdahl, R., Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur. J. Immunol. 1990. 20: 1061-1066.
8. Michaëlsson, E., Andersson, M., Engström, A. and Holmdahl, R., Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur. J. Immunol. 1992. 22: 1819-1825.
9. Myers, L., Terato, K., Seyer, J., Stuart, J. and Kang, A., Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J. Immunol. 1992. 149: 1439-1443.
10. Brand, D. D., Myers, L. K., Terato, K., Whittington, K. B., Stuart, J. M., Kang, A. H. and Rosloniec, E. F., Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J. Immunol. 1994. 152: 3088-3097.
11. Krco, C. J., Pawelski, J., Harders, J., McCormick, D., Griffiths, M., Luthra, H. S. and David, C. S., Characterization of the antigenic structure of human type II collagen. J. Immunol. 1996. 156: 2761-2768.
12. Lambert, L. E., Beding, J. S., Thompson, S. D., Harton, J. A., Bishop, G. A. and Choi, E., Polymorphism in the beta chain of IAq versus IAp influences presentation of protein but not peptide antigens. Cell. Immunol. 1995. 165: 202-210.
13. Michaëlsson, E., Broddefalk, J., Kihlberg, J., Engström, Å. and Holmdahl, R., Antigen processing and presentation of a naturally glycosylated proteinic elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur. J. Immunol. 1996. 26: 1906-1910.
14. Rosloniec, E. F., Whittington, K. B., Brand, D. D., Myers, L. K. and Stuart, J. M., Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Cell. Immunol. 1996. 172: 21-28.
15. Lambert, L. E. and Berling, J. S., Structural requirements for recognition of a type II collagen peptide by murine T cell hybridoma. Cell. Immunol. 1994. 153: 171-183.
16. Malmström, V., Michaëlsson, E., Burkhardt, H., Mattsson, R., Vuorio, E. and Holmdahl, R., Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc. Natl. Acad. Sci. USA 1996. 93: 4480-4485.
17. Michaëlsson, E., Malmström, V., Reis, S., Burkhardt, H., Engström, Å. and Holmdahl, R., T cell recognition of carbohydrates on type II collagen. J. Exp. Med. 1994. 30: 745-749.
18. Broddefalk, J., Bergquist, K.-E. and Kihlberg, J., Preparation of a glycopeptide analogue of type II collagen - use of acid labile protective groups for carbohydrate moieties in solid phase synthesis of O-linked glycopeptides. Tetrahedon Lett. 1996. 37: 3011-3014.
19. Romagnoli, P. and Germain, R., The CLIP region of invariant chain plays a critial role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 1994. 180: 1107-1113.
20. Gautam, A. M., Pearson, C., Quinn, V., McDevitt, H. O. and Milburn, P. J., Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 1995. 92: 335-339.
21. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994. 368: 215-221.
22. Busch, R., Hill, C., Hayball, J., Lamb, J. and Rothbard, J., Effect of natural polymorphism at residue 86 of the HLA-DRβ chain on peptide binding. J. Immunol. 1991. 147: 1292-1298.
23. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. and Sinigaglia, F., Promiscous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993. 74: 197-203.
24. Fremont, D. H., Hendrickson, W. A., Marrack, P. and Kappler, J., Structures of an MHC class II molecule with covalently bound single peptides. Science 1996. 272: 1001-1004.
25. Fugger, L., Liang, J., Gautam, A., Rothbard, J. B. and McDevitt, H. O., Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 1996. 2: 181-188.
26. Reizis, B., Mor, F., Eisenstein, M., Schild, H., Stefanovic, S., Rammensee, H. G. and Cohen, I. R., The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1. BI. Int. Immunol. 1996. 8: 1825-1832.
27. Wall, M., Southwood, S., Sidney, J., Oseroff, C., del Guericio, M. F., Lamont, A. G., Colon, S. M., Arrhenius, T., Gaeta, F. C. and Sette, A., High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants. Int. Immunol. 1992. 4: 773-777.
28. Wauben, M. H., Joosten, l., Schlief, A., van der Zee, R., Boog, C. J. and van Eden, W., Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide. J. Immunol. 1994. 152: 4211-4220.
29. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D. and Wraith, D. C., Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 1995. 3: 407-415.
30. Mason, K., Denney, D. J. and McConnell, H. M., Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH. J. Immunol. 1995. 154: 5216-5227.
31. Reay, P. A., Wettstein, D. A. and Davis, M. M., pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 1992. 11: 2829-2839.
32. Hill, C. M., Liu, A., Marshall, K. W., Mayer, J., Jorgensen, B., Yuan, B., Cubbon, R. M., Nichols, E. A., Wicker, L. S. and Rothbard, J. B., Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 1994. 152: 2890-2898.
33. Jones, T. A., Zou, J.-Y., Cowan, S. W. and Kjeldgaard, M., Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. 1991. A47: 110-119.
34. Powell, M. J. D., Restart procedures for the conjugate gradient method. Math. Program. 1977. 12: 241-254.
35. Laskowski, R. A., MacArthur, M. W., Moss, D. S. and Thornton, J. M., PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993. 26: 283-291.
36. Nicholls, A., Bharadwaj, R. and Honig, B., GRASP: Graphical Representation and Analysis of Surface Properties. Biophys. J. 1993. 64: 166-170.